Voyager Therapeutics, Inc.

NasdaqGS:VYGR Stock Report

Market Cap: US$316.3m

Voyager Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:VYGR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Oct 24SellUS$34,914Jacquelyn SandellIndividual5,999US$5.82
02 Apr 24SellUS$13,407Robin SwartzIndividual1,357US$9.88
02 Apr 24SellUS$119,454Alfred SandrockIndividual12,115US$9.86
21 Feb 24SellUS$28,079Peter PfreundschuhIndividual3,764US$7.46
21 Feb 24SellUS$97,226Alfred SandrockIndividual13,033US$7.46
21 Feb 24SellUS$29,760Todd CarterIndividual3,967US$7.68
21 Feb 24SellUS$29,547Robin SwartzIndividual3,966US$7.45
17 Jan 24SellUS$9,090Todd CarterIndividual1,266US$7.18
17 Jan 24SellUS$18,182Robin SwartzIndividual2,543US$7.15

Insider Trading Volume

Insider Buying: VYGR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VYGR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders604,2691.11%
Hedge Funds10,817,71919.8%
General Public16,710,79530.6%
Institutions26,492,80348.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.2%.

Top Shareholders

Top 25 shareholders own 59.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
EcoR1 Capital, LLC
5,617,719US$32.5m43.4%1.27%
9.94%
BlackRock, Inc.
5,430,430US$31.4m2.22%no data
9.52%
Armistice Capital LLC
5,200,000US$30.1m0%0.84%
5.83%
The Vanguard Group, Inc.
3,186,427US$18.4m4.87%no data
4.2%
Farallon Capital Management, L.L.C.
2,292,000US$13.3m0%0.09%
2.02%
Dimensional Fund Advisors LP
1,105,044US$6.4m35.8%no data
1.98%
Geode Capital Management, LLC
1,079,509US$6.3m0.63%no data
1.94%
Erste Asset Management GmbH
1,058,378US$6.1m0%0.05%
1.76%
Great Point Partners, LLC
959,953US$5.6m-40.1%2.28%
1.66%
T. Rowe Price Group, Inc.
905,820US$5.2m-8.46%no data
1.63%
State Street Global Advisors, Inc.
892,743US$5.2m-50.1%no data
1.01%
Federated Hermes, Inc.
551,398US$3.2m-0.51%0.01%
0.97%
Bank of America Corporation, Asset Management Arm
531,557US$3.1m-18%no data
0.93%
Morgan Stanley, Investment Banking and Brokerage Investments
509,780US$3.0m16.6%no data
0.9%
Vestal Point Capital, LP
490,000US$2.8m-18.3%0.25%
0.74%
Northern Trust Global Investments
406,371US$2.4m8.61%no data
0.61%
PGIM, Inc.
332,600US$1.9m248%no data
0.53%
GlobeFlex Capital LP
291,293US$1.7m0%0.13%
0.51%
Renaissance Technologies LLC
278,667US$1.6m341%no data
0.47%
Fiduciary Trust Company
259,397US$1.5m0%0.02%
0.46%
BNY Asset Management
249,528US$1.4m-15.3%no data
0.46%
AQR Capital Management, LLC
248,623US$1.4m-50.5%no data
0.45%
Citadel Advisors LLC
247,636US$1.4m114%no data
0.44%
Goldman Sachs Group, Investment Banking and Securities Investments
242,948US$1.4m-25.2%no data
0.43%
JP Morgan Asset Management
235,782US$1.4m-5.45%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 22:46
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Voyager Therapeutics, Inc. is covered by 25 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Jack AllenBaird
Aydin HuseynovBenchmark Company